Sodium-glucose co-transporter 2 inhibitor therapy: mechanisms of action in heart failure | Heart
Plausible mechanisms of action of SGLT2 inhibitor in hepatoprotection | Download Scientific Diagram
JCI Insight - Hyperglycemia induces skeletal muscle atrophy via a WWP1/KLF15 axis
SGLT2 Inhibition Mediates Protection from Diabetic Kidney Disease by Promoting Ketone Body-Induced mTORC1 Inhibition - ScienceDirect
Combined SGLT1 and SGLT2 Inhibitors and Their Role in Diabetes Care | Diabetes Technology & Therapeutics
SGLT2 Inhibitors – Diabetologia
Interaction of the Sodium/Glucose Cotransporter (SGLT) 2 Inhibitor Canagliflozin with SGLT1 and SGLT2: Inhibition Kinetics, Sidedness of Action, and Transporter-Associated Incorporation Accounting for its Pharmacodynamic and Pharmacokinetic Features ...
Mechanisms of Cardiovascular Benefits of Sodium Glucose Co-Transporter 2 ( SGLT2) Inhibitors: A State-of-the-Art Review - ScienceDirect
The renal hemodynamic effects of the SGLT2 inhibitor dapagliflozin are caused by post-glomerular vasodilatation rather than pre-glomerular vasoconstriction in metformin-treated patients with type 2 diabetes in the randomized, double-blind RED trial -
Scheme representing the proposed effects of SGLT2 inhibitor on NLRP3... | Download Scientific Diagram
Sodium-Glucose Cotransporter-2 inhibitors are potential therapeutic agents for treatment of non-diabetic heart failure patients - Journal of Cardiology
SGLT2 inhibitor dosing chart
SGLT2 inhibitors: mechanisms of cardiovascular benefit beyond glycaemic control | Nature Reviews Cardiology
References in SGLT2 Inhibitor–associated Diabetic Ketoacidosis: Clinical Review and Recommendations for Prevention and Diagnosis - Clinical Therapeutics
SGLT2 Inhibitor, Canagliflozin, Attenuates Myocardial Infarction in the Diabetic and Nondiabetic Heart | JACC: Basic to Translational Science
Sodium-Glucose Cotransporter 2 Inhibitors and Kidney Transplantation: What Are We Waiting For? | American Society of Nephrology
Sodium-Glucose Cotransporter 2 Inhibitors: An Overview
SGLT2 inhibitor - Wikipedia
The role of SGLT2 inhibitors in Type 2 Diabetes | BJFM
Effect of sodium glucose cotransporter 2 inhibitors on cardiac function and cardiovascular outcome: a systematic review | Cardiovascular Ultrasound | Full Text
SGLT2 inhibitors and GLP-1 receptor agonists: established and emerging indications - The Lancet
SGLT2 inhibitors: molecular design and potential differences in effect - Kidney International
![sglt-2_inhibitors [TUSOM | Pharmwiki]](https://tmedweb.tulane.edu/pharmwiki/lib/exe/fetch.php/sglt2.png "sglt-2_inhibitors [TUSOM | Pharmwiki]")
sglt-2_inhibitors [TUSOM | Pharmwiki]
